Sir, Polymyxin-based treatment is often considered as the last-line therapy for MDR Gram-negative bacterial infections. Resistance to polymyxins, in particular colistin, was previously linked to adaptive or mutational mechanisms involving chromosomally encoded genes before the discovery in late 2015 of a plasmid-mediated mobile colistin-resistance determinant (mcr-1). 1 The widespread dissemination of mcr-1 was subsequently discovered as this resistance determinant was found in at least 20 countries from various continents within a span of 3 months. 2 A retrospective study has shown that the mcr-1 gene can be traced back to the early 1980s, which coincides with the introduction of colistin into animal husbandry in China, 3 and hence the current distribution of MCR-1-producing Enterobacteriaceae may only represent the tip of the iceberg.
The mcr-1 gene has attracted significant interest due to its potential for horizontal transfer and impact on clinical treatment options. In order to gain insights into the localization and genetic organization of the mcr-1 gene, we sequenced six different STs of mcr-1-positive Escherichia coli strains (Table S1 , available as Supplementary data at JAC Online) that were previously isolated from various sources in Malaysia. 4 Genomic DNAs were extracted using a MasterPure DNA Purification Kit (Epicenter, Madison, WI, USA) and long-read sequencing was performed on a PacBio RS II instrument (Pacific Biosciences, Menlo Park, CA, USA). The singlemolecule sequencing reads were de novo assembled using Hierarchical Genome Assembly Process (HGAP) v. 3.0, and overlapping regions were assessed with Gepard followed by circularization using Minimus2 pipeline in the AMOS software package. The genomes were annotated via RAST and replicon sequences in the plasmids were analysed using PlasmidFinder (https://cge.cbs.dtu.dk/ services/). The genetic contexts of the mcr-1-harbouring plasmids and chromosome are summarized in Figure 1 .
pEC5-1, pEC13-1 and pS2.14-2 were IncI2 plasmids that shared over 96% of their sequences (at 99% nucleotide identity) with pmcr1_IncI2 (KU761326)-an mcr-1-harbouring plasmid that was isolated from a clinical ESBL-producing E. coli strain in China ( Figure S1 ). 5 The genetic context of mcr-1 in pEC5-1, pEC13-1 and pS2.14-2 was identical to that of pmcr1_IncI2 (nikB-mcr-1-pap), whereas, in pHNSHP45 (KP347127), an ISApl1 mobile element was inserted between nikB and mcr-1. The upstream ISApl1 insertion in mcr-1-bearing precursor plasmids such as pEC5-1, pEC13-1, pS2. 14-2 and pmcr1_IncI2 was hypothesized to be the key genetic event underlying the rapid mobilization and acquisition of this colistin-resistance gene. 6 In IncHl1 megaplasmids pEC2-4 and pEC2_1-4 the mcr-1-associated cassettes interrupted a gene that encodes a putative DNA repair protein and the pap elements were also found to be truncated. The ISApl1-mcr-1-Dpap-ISApl1 in pEC2-4 was bracketed by a 2 bp (TG) target site duplication, while, in pEC2_1-4, a 2961 bp deletion surrounding the downstream ISApl1 element resulted in a different genetic arrangement of ISApl1-mcr-1-DpapDorf unknown -int. Both plasmids also harboured other clinically relevant antibiotic resistance genes, including aadA1 (aminoglycoside), qnrS1 (fluoroquinolone), floR (florfenicol/chloramphenicol) and sul3 (sulphonamide), whereas only pEC2-4 carried an additional fosfomycin resistance determinant (fosA). pEC2-4 and pEC2_1-4 bear the closest resemblance to pB71 (KP899806; 63% query coverage; 99% nucleotide identity) and p109/9 (KP899805; 70% query coverage; 99% nucleotide identity), respectively, from Salmonella Typhimurium ( Figure S1 ). The finding of mcr-1-carrying IncHl1 plasmids in addition to previously reported classes of mcr-1-positive plasmids that include IncI2, IncF, IncX4, IncHl2 and IncP incompatibility groups 1,7-10 provided further evidence that transmission of this resistance gene occurred via distinct plasmids.
An ISApl1-mediated translocation of mcr-1 into the chromosome of E. coli was recently proposed by Veldman et al., 9 but the site of integration and the mcr-1-associated genetic structures were not reported. In the present study, multiple copies of ISApl1-mcr-1-Dpap that were arranged in tandem were found to be inserted between nhaA and sokC genes in the chromosome of clinical isolate EC590 resulting in a unique genetic arrangement of nhaA-ISApl1-mcr-1-Dpap-ISApl1-mcr-1-Dpap-ISApl1-mcr-1-Dpap-ISApl1-sokC, which was further confirmed by long-range PCR and Sanger sequencing. The presence of a 2 bp (TC) target site duplication flanking this genetic structure indicated that the triplicated mcr-1 gene locus was inserted via a transposition or recombination process. Sequences flanking the insertion site were high in AT content, which corresponded to the observations of Tegetmeyer et al.
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The information gathered from the complete genome sequencing of our E. coli strains and other studies showed that the mcr-1 gene is associated with diverse genetic structures and localizations. ISApl1 is most likely an important factor responsible for mcr-1 plasticity as well as for the integration of the resistance gene into various classes of plasmids and chromosomes. The insertion element could have played a role in the triplication of the mcr-1 locus, but the underlying mechanism remains unknown. The different STs of the mcr-1-positive E. coli isolates that were sequenced in this study supports the hypothesis that multiple horizontal transmission pathways may be responsible for the dissemination of this resistance gene. 8 Immediate revision regarding the use of colistin in agriculture is highly warranted to prevent the further spread of mcr-1-mediated colistin-resistant strains.
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None to declare. Sir, The emergence and rapid dissemination of Gram-negative pathogens carrying the plasmid-mediated colistin resistance mcr-1 gene have become a global threat to public health. 1 It is worrisome that the reservoirs for such organisms are increasing, not only in livestock, but also in wild animals and the environment. [2] [3] [4] In this regard, two recent reports published in JAC have described the presence of mcr-1-positive Escherichia coli in faecal samples of healthy wild birds (i.e. European herring gulls and kelp gulls). 3, 4 In this study, we report for the first known time the occurrence of E. coli carrying mcr-1 and bla CTX-M -type genes in infected migratory Magellanic penguins (Spheniscus magellanicus) suffering from bumblefoot (pododermatitis), highlighting a possible source of transmission of these organisms.
Supplementary data
Magellanic penguins are seabirds that live exclusively in the Southern Hemisphere (Argentina, Chile and Falkland/Malvinas Islands). 5 Brazil is on the migration route of this species and every year a large number of these birds arrive on beaches of the south and southeast coast, 5 where animals are kept in rehabilitation centres. Between 2006 and 2014, 261 penguins were admitted to a rehabilitation centre on the southeast coast of Brazil (23 59 0 10.7 00 S, 46 18 0 30.1 00 W). About 70% did not survive due to malnutrition and weakness developed during the migration period. In 2013, 24 animals succumbed to pododermatitis, which was associated with underlying infection of the footpad. 6 Samples collected from infected footpads of 13 animals were positive for E. coli.
As part of an antimicrobial resistance surveillance study, we have investigated these E. coli strains for transferable colistin resistance and production of ESBL, 7 leading to the identification of three ESBL-producing E. coli strains (ICBEC7P, ICBEC11P and ICBEC12P), which exhibited an MDR profile to ampicillin, ceftiofur, ceftazidime (8 mg/L), cefotaxime (.32 mg/L), cefepime, aztreonam, amikacin, gentamicin (32 mg/L), sulfamethoxazole/ trimethoprim, enrofloxacin, ciprofloxacin (.32 mg/L) and tetracycline (64 mg/L), as determined by disc diffusion or Etest methods. 7 ESBL production was confirmed by using a double-disc synergy test (DDST), and PCR screening and sequencing revealed bla CTX-M-1 in ICBEC7P and ICBEC11P, and bla CTX-M-2 in ICBEC12P. Although all isolates remained susceptible to ertapenem (0.016 mg/L), imipenem, meropenem and cefoxitin (1 mg/L), the E. coli strain ICBEC7P showed additional resistance to colistin (8 mg/L), 8 due to the presence of the mcr-1 gene. 1 The total genomic DNA of E. coli ICBEC7P was used to construct a paired-end library, which was sequenced using the MiSeq platform (Illumina). Genome assembly was carried out using SPAdes v3.9.0 and contigs were annotated using Prokka (www.github. com/tseemann/prokka). The 15.5 kbp contig containing the mcr-1 gene was found to bear an IncX4 replicon signature, as determined by the PlasmidFinder database (https://cge.cbs.dtu.dk/ser vices/PlasmidFinder/). Another 17.5 kbp contig was found to host a hit showing .99% identity to another IncX4 plasmid harbouring mcr-1, which we had sequenced using mate-pair reads (GenBank accession number CP015977). These two contigs were then concatenated with a gap, and the gap was closed and the plasmid circularized using the paired-end reads for ICBEC7P with GapFiller (www.baseclear.com/genomics/bioinformatics/basetools/ gapfiller). The complete circularized sequence of pICBEC7Pmcr was deposited in GenBank under accession number CP017246. Serotype, MLST ST, plasmid replicons, antimicrobial resistance genes and virulence genes for E. coli ICBEC7P were identified using the SerotypeFinder 1.1, MLST 1.8, PlasmidFinder 1.3, ResFinder 2.1 and VirulenceFinder 1.5 databases, respectively, available from the Center for Genomic Epidemiology (http://genomicepidemiology.org/).
The WGS analysis showed that E. coli ICBEC7P belonged to serotype ONT:H32 and MLST ST10. ST10 has been globally reported from livestock, food, human and environmental samples, being associ-
